Table 1.
Patient demographics and tumor histopathology characteristics
| n | % | |
|---|---|---|
| Age | Median 46 | Range 29–71 |
| Body mass index | ||
| <30 | 62 | 70.5 |
| ≥30 | 26 | 29.5 |
| Menopausal status | ||
| Premenopausal | 53 | 60.0 |
| Postmenopausal | 35 | 40.0 |
| Pathologic stage* | ||
| I | 11 | 12.5 |
| II A | 31 | 35.0 |
| II B | 27 | 31.0 |
| III A | 19 | 21.5 |
| Axillary status | ||
| Positive | 55 | 52.5 |
| Negative | 33 | 37.5 |
| Estrogen receptor | ||
| Positive | 50 | 57.0 |
| Negative | 38 | 43.0 |
| Progesterone receptor | ||
| Positive | 59 | 67.0 |
| Negative | 29 | 33.0 |
| Grade | ||
| I | 10 | 11.0 |
| II | 35 | 40.0 |
| III | 43 | 49.0 |
*
According to American Joint Committee on Cancer 2002